Skinvisible, Inc. is focused on developing innovative technology and superior topical polymer delivery vehicles to significantly enhance product performance for established brand manufacturers and marketers of Rx and OTC dermatological, medical, cosmetic and skincare products.

Skinvisible has developed a patented family of polymer delivery vehicles called Invisicare. The company uses the Invisicare technology to produce a variety of prescription dermatology and over-the-counter skincare products along with hospital-related and consumer goods products that address a variety of medical conditions.

The company conducts in-house research, development and testing of its Invisicare polymer delivery vehicles as well as the products formulated with Invisicare. In addition, where appropriate for validation and independent verification of marketing claims, it utilizes FDA registered independent laboratories for carrying out investigative product studies, utilizing protocols incorporating Good Lab Practice and Good Clinical Practice (”GLP/GCP”) standards.

Let us hear your thoughts: Skinvisible, Inc. Message Board

Skinvisible, Inc., a pharmaceutical research and development company, announced that the company has entered into an exclusive license agreement with Mayquest Pharmaceuticals Pte. This license agreement grants Skinvisible the exclusive rights for the product Dermsafe in Singapore, Malaysia, Thailand, Indonesia, and the Philippines. Dermsafe is a patented antimicrobial hand sanitizer lotion proven to kill the H1N1 swine flu virus.

Under the terms of this agreement, Mayquest is to pay an upfront license fee in milestones for the exclusive manufacturing and marketing right. Skinvisible will also receive on-going royalties derived from product sales.

Mr. Terry Howlett, President and CEO of Skinvisible, stated, “Mayquest is an excellent partner to bring DermSafe to both the retail and healthcare market in Southeast Asia”

Howlett added, “This agreement represents an important step in accelerating our worldwide approval and commercialization of DermSafe for the prevention of the spread of the swine flu and other viruses and bacteria. Mayquest

Pharmaceuticals and dermatology go hand in hand. Existing skin care products cover a wide range of capabilities. Some are to aide with an allergic reaction. Some slow the elasticity process of aging. Some offer concealment to blemishes. Whatever the type used, this industry is huge, really huge. Even as we live in such uncertain times, the salon and skin care industries are running at peak performance. It is not just one or two areas of that market doing well either, it is abroad. Because of technology accompanied by a host of pharmaceutical scientists, researchers, and those dedicated to the skin care industry, it is constantly blooming with new activity.

Topically delivered products are becoming more popular by the day. It is these products that boast how far technology has come. These products protect the skin from environmental irritants and allows for normal skin respiration while reducing overall irritation. Concepts